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Results
Rat GluR7b, a New Carboxy-Terminal Splice
Variant of GluR7
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match Detect II Kit, Ambion) was used to localize and
identify new RNA splice variants in the GluR7 subunit
mRNA (see Experimental Procedures). This screen iden-Summary
tified a new putative splice variant of the GluR7 tran-
script. A 40 nucleotide cassette was frequently foundGlutamate receptors of the kainate-preferring subtype
inserted after nucleotide position 2565 in the GluR7have recently been shown to mediate synaptic trans-
mRNA, 42 nucleotides downstream (39) from the regionmission in the hippocampus. The low-affinity kainate
encoding the fourth membrane domain (M4; Figure 1A).receptor subunit GluR7 was found to be nonfunctional
The insertion of the cassette into the GluR7 open readingin previous studies. We report here that the GluR7
frame causes a frame shift downstream of the insertionsubunit and a novel carboxy-terminal splice variant,
point, resulting in an alternatively spliced mRNA encod-GluR7b, are functional glutamate receptors with unique
ing a receptor subunit with a new carboxyl terminuspharmacological properties. In particular, glutamate
(Figures 1A and 1B). The new splice variant was namedexhibits a 10-fold lower potency for (non-desensitized)
GluR7b, and the originally cloned subunit was renamedGluR7-mediated currents as compared to other non-
GluR7a (Bettler et al., 1992). The carboxyl terminus ofNMDA receptor channels. These data will facilitate
the GluR7b protein is 69 amino acids in length and di-understanding of the distinct role played by GluR7
verges from GluR7a after Q825, which is localized 14receptors in synaptic transmission.
amino acids after the end of M4. The additional 55 amino
acids after the splice site in the GluR7b carboxyl termi-
nus are composed of the 13 residues encoded by theIntroduction
40 nucleotide cassette and an additional 42 amino acids
encoded by the new open reading frame that resultsIonotropic glutamate receptors mediate excitatory syn-
from the frame shift. Splice variation at analogous posi-aptic transmission in the mammalian central nervous
tions in GluR2, GluR4, GluR5, and GluR6 suggests thatsystem (CNS). These receptors are classified into
this site is conserved in non-NMDA receptor subunitsa-amino-3-hydroxy-5-methyl-4-isoxazole-propionate
(reviewed by Sprengel and Seeburg, 1995). The protein(AMPA), kainate, and N-methyl-D-aspartate (NMDA) re-
sequence of the GluR7b carboxy-terminal domain (fol-ceptor subunits (reviewed by Hollmann and Heinemann,
lowing the splice site) exhibits no significant homology1994; Sprengel and Seeburg, 1995). While AMPA and
to known sequences from other glutamate receptor sub-NMDA receptorshave been shown to underlieexcitatory
units. Additionally, this region contains a preferred
synaptic currents, the function of the kainate subfamily
consensus site for protein kinase C-dependent (PKC-
of receptors is less clear. There are five cloned rat kai-
dependent) phosphorylation (Pearson and Kemp, 1991).
nate receptor subunits, which are subdivided into ªlow
A second PKC consensus sequence is found 10 amino
affinityº (GluR5±7) and ªhigh affinityº (KA-1 and KA-2)
acids beyond this site outside the 13 amino acid cas-
subunit families (reviewed by Hollmann and Heinemann,
sette (Figure 1B).
1994). Only two members of this receptor family, GluR5
To understand how theorganization of the GluR7 gene
and GluR6, have been shown to form functional homo-
is related to the splice variant, we performed PCR reac-
meric channels (Egebjerg et al., 1991; Bettler et al., 1992;
tions on genomic rat DNA. Primers complementary to
Sommer et al., 1992; KoÈ hler et al., 1993). Despite exten- a segment of the 40 nucleotide insertion, paired with
sive investigations, the remaining kainate receptor sub-
primers based on the flanking sequences of the cDNA,
unit, GluR7, seemed incapable of forming functional ho- were used to amplify the upstream and downstream
momeric channels or altering the properties of other genomic sequences (the positions of the genomic prim-
receptors in coexpression studies (Bettler et al., 1992; ers are illustrated in Figure 1A). Two different amplifica-
Lomeli et al., 1992; Partin et al., 1993; Nutt et al., 1994). tion reactions were performed to obtain the downstream
We describe here the cloning and characterization of genomic DNA sequence. Analyzing the reactions by
GluR7b, a novel carboxy-terminal splice variantof GluR7 DNA electrophoresis revealed PCR products with sizes
(which we have renamed GluR7a). In contrast to previ- smaller than 100 bp. The sequence of five subcloned
ous findings, we demonstrate that GluR7a and -7b are amplification products from each reaction consistently
functional kainate receptors with distinct pharmacologi- gave a 64 bp or 77 bp DNA fragment, depending on
cal properties. GluR7a has a z10-fold higher EC50 for the primer used (see Figure 1A). The DNA sequences
glutamate compared to other cloned AMPA or kainate amplified between the primers showed that the GluR7
receptors, suggesting that this receptor may play a splice site was flanked upstream by sequences identical
unique role in neurotransmission in the CNS. to the 40 nucleotide cassette and was flanked down-
stream by GluR7a cDNA sequences. These results indi-
cate that the splicing event in GluR7 transcripts results*To whom correspondence should be addressed.
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Figure 1. Alternative Splicing in the Rat GluR7 Transcript Generates mRNA Coding for GluR7b, a New Carboxy-Terminal Splice Variant of
GluR7
(A, top) The intron-exon structure of the rat GluR7 gene showing the splice sites is illustrated. PCR analysis of the GluR7 gene structure
indicated that the 40 nucleotide insertion in GluR7b mRNA is the result of using an alternative 39 splice site. The positions of the PCR primers
used in this analysis and the size of the obtained amplification products is shown.
(A, bottom) Partial DNA sequences of GluR7a and GluR7b mRNA are shown to indicate the position of the splice site (after nucleotide 2565
in GluR7 cDNA; A in start codon is referred to as nucleotide one). The sequence of the 40 nucleotide insertion is underlined. The GluR7b
cDNA sequence has been submitted to the GenBank database with the accession number AF027331.
(B) The amino acid sequences of the GluR7 and GluR7b carboxyl termini are aligned starting after membrane domain 4 (M4). The underlined
13 amino acids of GluR7b are encoded by the 40 nucleotide cassette of the GluR7b mRNA. Serine and threonine residues contained in
consensus sites for protein kinase C-mediated phosphorylation (Pearson and Kemp, 1991) are marked by black dots.
from the use of an alternative 39 splice site (Figure 1A). had a very low sensitivity to glutamate. At high concen-
trations (30 mM), 100 ms pulses of glutamate evokedWe were not able to amplify the GluR7 genomic se-
quence between the insertion and the 59 flanking primer, currents with a 10%±90% rise time of 1.4 6 0.1 ms
and a mean peak amplitude of 1.1 6 0.2 nA (n 5 24).which suggests the presence of a large intron. To verify
the fidelity of the splicing event, additional RT-PCR frag- Glutamate currents desensitized with a tdes of 8.4 6 0.5
ms (n 5 23) and exhibited very little steady-state currentments containing the insertion were subcloned. Se-
quence analysis of both DNA strands using five different (95.9% 6 1.6% desensitization from the peak current).
GluR7b also formed functional glutamate receptorsprimers showed no nucleotide variation. RT-PCR analy-
sis indicated that the GluR7b mRNA was expressed at when expressed in HEK 293 cells (Figure 2B). The mean
amplitude of glutamate currents evoked from GluR7b5- to 10-fold lower levels than GluR7a mRNA during
development of the rat brain (data not shown). was z7-fold smaller than that from GluR7a (mean peak
amplitude of 163 6 81 pA; n 5 8). GluR7b current rise
times were slower than GluR7a (2.2 6 0.5 ms versus 1.4Homomeric GluR7 Is a Functional Kainate Receptor
with Low Sensitivity to Glutamate ms using 30 mM glutamate; significantly different at
p , 0.05, unpaired t test). GluR7b glutamate currentsSurprisingly, we discovered that both GluR7a and
GluR7b subunits generated functional homomeric re- desensitized with a t equal to 9.0 6 1.7 ms, a time course
that was indistinguishable from that of GluR7a (p 5ceptors (Figures 2A and 2B) after transient transfection
of human embryonic kidney (HEK) 293 cells. Rapid appli- 0.63). Because of the relatively small currents elicited
from GluR7b, we chose to focus primarily on GluR7acation of agonist to cells lifted from coverslips revealed
that GluR7a shows current responses similar to those for further characterization.
We carried out a dose-response analysis to estimateof GluR5 and GluR6 kainate receptors, but with a number
of distinct pharmacological features. In particular, GluR7a the EC50 value for the peak current evoked by glutamate
(Figures 2A and 2C). Responses to increasing concen-demonstrates a markedly higher peak (non-desensi-
tized) EC50 for glutamate as compared to other non- trations of glutamate were normalized to control appli-
cations of 30 mM glutamate. To derive an estimatedNMDA glutamate receptors. Application of 1 mM gluta-
mate gave small currents exhibiting relatively slow rise EC50 for glutamate, we fitted the data to the Hill equation,
which gave an EC50 of z6 mM and a Hill coefficient oftimes and rapid desensitization (Figure 2A). Application
of higher concentrations of glutamate dramatically in- 1.5 (n 5 3 or 4 for each concentration; the maximal
normalized response for the fitted curve was 1.06). Thiscreased the current amplitudes, suggesting that GluR7a
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Figure 2. GluR7a, a Functional Receptor with
Low Sensitivity to L-Glutamate
(A) Currents evoked from a GluR7a-express-
ing HEK 293 cell at increasing concentrations
of glutamate (1±30 mM).
(B) Currentevoked from a GluR7b-expressing
HEK 293 cell at 30 mM glutamate. Glutamate
was applied for 100 ms in (A) and (B), and the
holding potentials were 280 mV.
(C) Concentration-response curve for gluta-
mate on GluR7a receptors. Peak GluR7a re-
sponses at each concentration were normal-
ized against a 30 mM glutamate response
given 30 s prior to the test concentration
(squares). The same solution set used to gen-
erate two full GluR7aconcentration-response
curves was tested on a GluR4-expressing
HEK 293 cell (circles). Data were fitted to the
Hill equation and gave an EC50 of 5.9 mM for
GluR7a and 0.56 mM for GluR4.
(D) GluR7a currents evoked by 30 mM gluta-
mate at different voltages. Cells were initially
held at voltages ranging from 280 to 60 mV.
Glutamate (30 mM) was applied for 100 ms.
The measured current-voltage relationship
for the GluR7a peak glutamate currents is in-
dicated by the circles. Data were fitted to a
third-order polynomial equation.
fit predicts that the GluR7a receptor will be 91% satu- kainate evokes a very small current as compared to
higher concentrations (5±10 mM; data not shown).rated at 30 mM glutamate. In a control experiment with
GluR7a, like GluR6, does not respond to AMPA (1 mM;the same solution set as was used with GluR7a, gluta-
Figure 3A). Finally, unlike the other AMPA and kainatemate displayed a 10-fold higher potency on the homo-
receptors, GluR7a receptors are insensitive to the high-meric AMPA receptor GluR4 (EC50 5 0.56 mM, nH 5 1.07;
affinity ligand domoate (100 mM, n 5 9; Figure 3A). Appli-Figure 2C). Similarly, the EC50 of glutamate on homo-
cations of domoate attenuated subsequent glutamatemeric GluR6 receptors has been reported as 0.5 mM
currents for minutes (data not shown), confirming that(Heckmann et al., 1996).
this agonist appears to act as a high-affinity antagonistGluR7a contains a glutamine at the glutamine/arginine
on GluR7 receptors.(Q/R) site in M2 and does not appear to undergo RNA
Steady-state currents of kainate receptors are po-editing at this site (Bettler et al., 1992; Lomeli et al.,
tentiated by plant lectins, the most efficacious of which1992). Kainate receptors that have a glutamine residue
is concanavalin A (con A; Partin et al., 1993; Yue et al.,at this site show characteristic channel properties,
1995). We tested whether GluR7a was also potentiatedwhich include a higher calcium permeability (KoÈ hler et
by con A. After treatment for 1.5 minutes with 0.3 mg/al., 1993) and sensitivity to intracellular polyamines that
ml con A, GluR7a peak currents were modestly in-produce current rectification (Kamboj et al., 1995). As
creased (2.1-fold 6 0.2-fold, n 5 5; p , 0.05, paired tis shown inFigure 2D, GluR7a exhibits thesame inwardly
test), but steady-state currents were unchanged (Figure
rectifying currents seen with other glutamine-containing
3B). Identical con A treatments were sufficient to po-
AMPA and kainate receptor subunits. Applications of 30
tentiate GluR6 steady-state currents by several orders
mM glutamate to cellsheld at voltages stepped between of magnitude (data not shown), as has been reported
280 and 60 mV gave a peak current-voltage relationship previously (Partin et al., 1993).
that reversed near 0 mV and exhibited little outward
current at positive potentials. GluR7a Coassembles with KA-1 and KA-2 Subunits
to Form Functional Heteromeric Receptors
Pharmacology of Homomeric GluR7a Receptors GluR7a was coexpressed with the KA-1 and KA-2 sub-
The two well-characterized kainate receptor subunits, units to determine whether these subunits altered the
GluR5 and GluR6, can be pharmacologically differenti- pharmacological or kinetic properties of the GluR7a
ated by the kinetics of their responses to the agonists channel, as they do with GluR5 and GluR6. As shown
kainate, AMPA, and domoate (Sommer et al., 1992; in Figure 4, GluR7a/KA-1 and GluR7a/KA-2 channel
KoÈ hler et al., 1993). We assayed the sensitivity and cur- properties were similar to those of GluR7a. However,
rent kinetics of GluR7a in response to application of we found that the heteromeric channels were activated
these agonists (Figure 3A). Kainate (5 mM) evokes a by high concentrations of AMPA, in contrast to homo-
desensitizing current with a tdes equal to 3.2 6 0.4 ms meric GluR7a receptors, which were completely insensi-
(n 5 7), similar to that seen with GluR6. As with gluta- tive to this agonist. Both GluR7a/KA-1 and GluR7a/
mate, GluR7a is markedly less sensitive to kainate as KA-2 glutamate currents desensitized rapidly and al-
most completely in response to a 100 ms applicationcompared to other non-NMDA receptors, since 1 mM
Neuron
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Figure 3. Pharmacology of Homomeric GluR7
Receptors
(A) Application of 30 mM glutamate, 5 mM
kainate, 1 mMAMPA, and 100 mM domoate to
HEK 293 cells expressing GluR7a. Glutamate,
kainate and AMPA were applied for 100 ms;
domoate was applied for 1 s. No currents
were detected during domoate application at
faster time resolution. The holding potential
was 280 mV.
(B) Glutamate-evoked currents from a
GluR7a-expressing cell before (left) and after
(right) application of 0.3 mg/ml concanavalin
A (con A) for 1.5 min. Glutamate was applied
for 100 ms. Longer incubations (up to 5 min)
with con A did not alter the response beyond
the potentiation seen after a 1.5 min appli-
cation.
(GluR7a/KA-1, mean peak amplitude 5 700 6 285 pA, AMPA currents desensitized relatively slowly, with a
tdes 5 30 6 12 ms. AMPA-evoked currents were ob-tdes 5 7.6 6 1.3 ms, 97.3% desensitization, n 5 8;
GluR7a/KA-2, mean peak amplitude 5 232 6 70 pA, served in all cells expressing GluR7a/KA-2 cells that we
tested (n 5 5) and were of relatively small amplitudetdes 5 5.3 6 0.9 ms, 96.5% desensitization, n 5 9). The
GluR7a/KA-2 glutamate currents desensitized signifi- (44 6 10 pA, 21% 6 6% of the peak glutamate current;
Figure 4B).Finally, in two of five cellsexpressing GluR7a/cantly faster than did GluR7a glutamate currents (5.3
ms versus 8.4 ms, p , 0.05). Kainate currents from KA-1 we observed a small response to 100 mM domoate
(16 and 19 pA; see example in Figure 4A). Domoatethe heteromeric channels exhibited kinetics similar to
GluR7a (GluR7a/KA-1, mean peak amplitude 5 475 6 currents were not detected in GluR7a/KA-2-expressing
cells (n 5 7). The sensitivity we observed for AMPA282 pA, tdes 5 3.7 6 0.1 ms, 99.7% desensitization, n 5
3; GluR7a/KA-2, mean peak amplitude 5 166 6 64 pA, demonstrate that GluR7a subunits can coassemble with
the high-affinity kainate receptor subunits KA-1 andtdes 5 2.4 6 0.2 ms, 98.2% desensitization, n 5 4). On
GluR7a/KA-1 channels, AMPA (1 mM) gave currents with KA-2 to produce heteromeric channels. In the case of
GluR7a/KA-2, coassembly also increases the rate of de-mean amplitudes of 115 6 46 pA (11% 6 2% of the
peak glutamate current) in three of six cells (Figure 4A). sensitization to glutamate.
Figure 4. KA-1 and KA-2 Subunits Coassem-
ble with GluR7a to Form Heteromeric Re-
ceptors
(A) Application of 30 mM glutamate, 5 mM
kainate, 1 mM AMPA and 100 mM domoate
to HEK 293 cells coexpressing GluR7a/
KA-1. Drugs were applied for 100 ms. Do-
moate currents were seen in only two of five
cells. The holding potential was 280 mV.
(B) Application of 30 mM glutamate, 5 mM
kainate, 1 mM AMPA, and 100 mM domoate
to HEK 293 cells coexpressing GluR7a/KA-2.
Glutamate, kainate, and AMPA were applied
for 100 ms; domoate was applied for 1 s.
No currents were detected during domoate
application at faster time resolution. The
holding potential was 280 mV.
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Discussion (8.6 ms). Our results are also incompatible with the idea
that (for GluR7a) concanavalin A primarily impedes entry
into a desensitized state from the peak open state, sinceWe show here that GluR7 receptor subunits form func-
tional ionotropic glutamate receptors with unique chan- no effect on either the desensitization rate or degree of
desensitization was observed. The lack of a markednel properties, in contrast to our previous results (Bettler
et al., 1992) and those of others (Lomeli et al., 1992; effect on GluR7a steady-state currents is surprising
given the similarity of the GluR6 and GluR7a responsesPartin et al., 1993; Nutt et al., 1994). Dose-response
curves revealed that GluR7a receptors display the low- to glutamate. Furthermore, GluR5, GluR6, and GluR7
are predicted to have the same N-glycosylation sites. Ifest sensitivity for glutamate found among the identified
members of the non-NMDA receptor family. GluR7 also these sites are glycosylated to an equivalent degree,
our results suggest that other domains of the subunitshows some interesting pharmacological differences
from the evolutionarily related receptors GluR5 and protein in part determine the functional effect of con A.
GluR6Ðin particular, its insensitivity to domoate and
the weak potentiating effect of con A. These data will A Low-Affinity Glutamate Receptor
facilitate efforts to understand the role of kainate recep- and Synaptic Transmission
tors, and GluR7 receptors in particular, in neurotrans- While a number of examples of currents arising from
mission and CNS disorders. kainate receptors have been described in neurons
(Huettner, 1990; Lerma et al., 1993; Wilding and Huett-
ner, 1997), including synaptic kainate receptors (Vignes
Comparison of GluR7 Properties with Other and Collingridge, 1997; Castillo et al., 1997), none can
Kainate Receptors yet be definitively ascribed to GluR7-containing recep-
In addition to its lower sensitivity to glutamate, GluR7 tors. However, if these receptors are indeed localized
exhibits functional differences from GluR5 and GluR6 in to the synapse, our results raise the interesting question
its response to other glutamatergic agonists. The ab- of whether the synaptic concentration of glutamate typi-
sence of currents with application of the high-affinity cally reaches levels sufficient to activate homomeric
ligand domoate is particularly surprising, since all other GluR7 receptors. A number of factors, including the syn-
functional non-NMDA glutamate receptors respond to aptic architecture, location of the receptors, and neuro-
this compound with relatively high affinity. In the case transmitter clearance mechanisms, could produce dif-
of the agonist AMPA, the lack of a response correlates ferent glutamate concentration profiles in individual
with our recent work, which determined that serine 721 synapses (reviewed by Clements, 1996). A recent inves-
in the GluR5 subunit (corresponding to asparagine 721 tigation into the activation of synaptic AMPA receptors
and asparagine 722 in GluR6 and GluR7, respectively) in the presence of a low-affinity antagonist yielded an
is responsible for conferring sensitivity to high concen- estimated peak glutamate concentration in the cleft of
trations of AMPA(Swanson et al., 1997). Our observation z3 mM (Diamond and Jahr, 1997), which would be pre-
that GluR7a is insensitive to AMPA therefore is consis- dicted to be subsaturating at synaptic (homomeric)
tent with the presence of an asparagine at this site. The GluR7 receptors. It has also been suggested that a pop-
distinct pharmacology exhibited by GluR7a as com- ulation of kainate receptors is localized presynaptically
pared to other kainate receptors will be a useful tool (Chittajallu et al., 1996; but see also Castillo et al., 1997).
to investigate its role in synaptic transmission and to If GluR7 receptors are located near the vesicle fusion
characterize important ligand-binding and gating do- pore during release, they would see higher glutamate
mains on the receptor proteins. Domoate, in particular, concentrations than those at the postsynaptic mem-
will be a useful probe for residues involved in gating, brane (Clements, 1996). Alternatively, postsynaptic GluR7
since this compound binds with high affinity (Lomeli et receptors may be fully activated under conditions of
al., 1992) but does not appear to translate that binding augmented synaptic glutamate concentrations, which
energy into channel activation. can result from multivesicular release (Tong and Jahr,
ConcanavalinA hasbeen shown to stronglypotentiate 1994). GluR7 receptors are likely to be calcium perme-
GluR5 and GluR6 receptor steady-state currents (Partin able, since they contain a glutamine at the Q/R site and
et al., 1993), but we found only modest effects on GluR7 have rectifying current-voltage relationships, and may
(Figure 3B). Peak glutamate currents evoked from re- therefore contribute to synaptic calcium signaling under
combinant GluR6 receptors were also potentiated by such conditions of strengthened neurotransmission. It
z2-fold after treatment with con A (Partin et al., 1993), is therefore possible that GluR7 receptors act as high-
as were kainate receptor currents in dorsal root ganglia threshold filters for discrimination of the strength of ex-
(DRG; Huettner, 1990) and trigeminal neurons (probably citatory synaptic input, with stronger signals resulting
composed of GluR5 and KA-2; Sahara et al., 1997). In in significant calcium influx.
the case of the GluR6 receptor, the 2-fold potentiation
was suggested to arise in part from the combination of Experimental Procedures
a slowed entry into the desensitized state after treatment
Detection and Analysis of Splicing in the GluR7 Transcriptwith con A and poor resolution of the peak currents due
We screened GluR7 transcripts for novel RNA editing or splicingto limitations in the solution exchange. These problems
events using the Mismatch Detect II Kit (Ambion, Austin, TX). Totalare unlikely to explain the lack of a large con A potentia-
RNA from rat brain was reverse transcribed with a primer specific
tion of GluR7a, since the activation rate both before for theGluR7 gene using AMV reverse transcriptase(Promega, Mad-
(10%±90% rise time of 1.4 ms) and after (1.6 ms) con A ison, WI). This was followed by two-step nested PCR reactions (35
cycles each) catalyzed by TAQ2000 polymerase (Stratagene, Latreatment was 5-fold faster than the desensitization rate
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Jolla, CA). Primers for the first PCR reactions generated overlapping Diamond, J.S., and Jahr, C.E. (1997). Transporters buffer synapti-
cally released glutamate on a submillisecond time scale. J.Neurosci.products that covered the open reading frame of the GluR7 gene.
The second nested PCR reactions used an aliquot of the first PCR 17, 4672±4687.
reactions and nested primers that were tailed with sequences con- Egebjerg, J., Bettler, B., Hermans-Borgmeyer, I., and Heinemann,
taining the T7 and SP6 promoters. Unpurified RT-PCR products S. (1991). Cloning of a cDNA for a glutamate receptor subunit acti-
were used as described by the manufacturer (Ambion) to detect vated by kainate but not AMPA. Nature 351, 745±748.
mismatches. The sequence analysis of subcloned RT-PCR products Heckmann, M., Bufler, J., Franke, C., and Dudel, J. (1996). Kinetics
determined that the observed mismatch was caused by the insertion of homomeric GluR6 glutamate receptor channels. Biophys. J. 71,
of a 40 nucleotidesegment into the GluR7 mRNA. We also performed 1743±1750.
PCR amplifications on genomic DNA with primers complementary
Hollmann, M., and Heinemann, S. (1994). Cloned glutamate recep-to a segment of the 40 nucleotide insertion, paired with primers
tors. Annu. Rev. Neurosci. 17, 31±108.complementary to GluR7 cDNA sequences flanking the insertion.
Huettner, J.E. (1990). Glutamate receptor channels in rat DRG neu-The genomic PCR fragments amplified were subcloned and ana-
rons:activation by kainate and quisqualate and blockade of desensi-lyzed by DNA sequencing.
tization by Con A. Neuron 5, 255±266.
Kamboj, S.K., Swanson, G.T., and Cull-Candy, S.G. (1995). Intracel-
Electrophysiology lular spermine confers rectification on rat calcium-permeable AMPA
GluR7a cDNA was subcloned into the high-expression vector pCI- and kainate receptors. J. Physiol. (Lond.) 486, 297±303.
neo (Promega), which was then used as template for PCR-based
KoÈ hler, M., Burnashev, N., Sakmann, B., and Seeburg, P.H. (1993).introduction of the 40 nucleotide insertion present in GluR7b tran-
Determinants of Ca21 permeability in both TM1 and TM2 of highscripts. HEK 293 cells were maintained in DMEM media supple-
affinity kainate receptor channels: diversity by RNA editing. Neuronmented with 100 mg/ml penicillin, 100 mg/ml streptomycin, and 10%
10, 491±500.FCS. Transfection of receptor cDNAs was done by standard cal-
Lerma, J., Paternain, A.V., Naranjo, J.R., and Mellstrom, B. (1993).cium-phosphate precipitation as described in Swanson et al. (1997).
Functional kainate-selective glutamate receptors in cultured hippo-Electrophysiological recordings were made after identification of
campal neurons. Proc. Natl. Acad. Sci. USA 90, 11688±11692.transfected cells using polystyrene beads coated with anti-CD8 anti-
body (Dynal, Lake Success, NY). Patch-clamp recordings were per- Lomeli, H., Wisden, W., KoÈ hler, M., KeinaÈ nen, K., Sommer, B., and
formed as described in Swanson et al. (1997). Drugs were applied Seeburg, P.H. (1992). High-affinity kainate and domoate receptors
through three-barrel glass tubing (Vitro Dynamics, Rockaway, NJ) in rat brain. FEBS Lett. 307, 139±143.
mounted on a piezo-ceramic bimorph. The piezo bimorph was driven Nutt, S.L., Hoo, K.H., Rampersad, V., Deverill, R.M., Elliott, C.E.,
by pClamp 6.03 software (Axon Instruments) fed through a stimula- Fletcher, E.J., Adams, S.L., Korczak, B., Foldes, R.L., and Kamboj,
tion-isolation unit (S-100, Winston Electronic, Millbrae, CA). Data R.K. (1994). Molecular characterization of the human EAA5 (GluR7)
were acquired directly to a computer and were analyzed offline receptor: a high-affinity kainate receptor with novel potential RNA
using pClamp software. Dose-response curves were fitted to the editing sites. Receptors Channels 2, 315±326.
Hill equation using SigmaPlot software (Jandel Scientific). L-gluta-
Partin, K.M., Patneau, D.K., Winters, C.A., Mayer, M.L., and Buo-mate and concanavalin A were purchased from Sigma Biochemicals
nanno, A. (1993). Selective modulation of desensitization at AMPA(St. Louis, MO); other drugs were from Tocris (Ballwin, MO).
versus kainate receptors by cyclothiazide and concanavalin A. Neu-
ron 11, 1069±1082.
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